![]() |
Volumn 24, Issue 8, 2006, Pages 909-913
|
Translating in vivo diagnostics into clinical reality
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAGNOSTIC AGENT;
FANOLESOMAB TC 99M;
GADOBENATE DIMEGLUMINE;
IMATINIB;
LIPID;
PERFLEXANE;
PERFLUTREN;
TOSITUMOMAB I 131;
ANGIOGENESIS;
BREAST CARCINOMA;
BREAST DUCT;
CANCER;
CANCER DIAGNOSIS;
CHRONIC MYELOID LEUKEMIA;
COLORECTAL CANCER;
COMPUTER ASSISTED TOMOGRAPHY;
DIABETES MELLITUS;
DIAGNOSTIC IMAGING;
DIAGNOSTIC PROCEDURE;
DIAGNOSTIC TEST;
DISEASE COURSE;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH CARE COST;
HEALTH CARE ORGANIZATION;
HODGKIN DISEASE;
HUMAN;
LUNG CANCER;
NONHUMAN;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT CARE;
POSITRON EMISSION TOMOGRAPHY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROSTATE CANCER;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
TESTIS CANCER;
UNITED STATES;
X RAY;
CLINICAL MEDICINE;
DRUG INDUSTRY;
MOLECULAR DIAGNOSTIC TECHNIQUES;
TECHNOLOGY TRANSFER;
UNITED STATES;
UNIVERSITIES;
|
EID: 33747066097
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0806-909 Document Type: Note |
Times cited : (40)
|
References (14)
|